Bristow RE - Search Results

1

Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis.

Kim JH, Kim SI, Park EY, Ha HI, Kim JW, Coleman RL, Bristow RE, Park SY, Fotopoulou C, Lim MC. Kim JH, et al. Among authors: bristow re. Gynecol Oncol. 2023 Oct 27;179:24-32. doi: 10.1016/j.ygyno.2023.10.018. Online ahead of print. Gynecol Oncol. 2023. PMID: 39491079

2

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Bristow RE, et al. Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. Gynecol Oncol. 1999. PMID: 10053096

3

Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.

Bristow RE, Asrari F, Trimble EL, Montz FJ. Bristow RE, et al. Gynecol Oncol. 2001 May;81(2):279-86. doi: 10.1006/gyno.2001.6159. Gynecol Oncol. 2001. PMID: 11330963

4

Micropapillary serous ovarian carcinoma: surgical management and clinical outcome.

Bristow RE, Gossett DR, Shook DR, Zahurak ML, Tomacruz RS, Armstrong DK, Montz FJ. Bristow RE, et al. Gynecol Oncol. 2002 Aug;86(2):163-70. doi: 10.1006/gyno.2002.6736. Gynecol Oncol. 2002. PMID: 12144823

5

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT.

Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ. Bristow RE, et al. Gynecol Oncol. 2003 Sep;90(3):519-28. doi: 10.1016/s0090-8258(03)00336-6. Gynecol Oncol. 2003. PMID: 13678719 Clinical Trial.

6

Surgical care of elderly women with ovarian cancer: a population-based perspective.

Díaz-Montes TP, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Gordon TA, Armstrong DK, Bristow RE. Díaz-Montes TP, et al. Among authors: bristow re. Gynecol Oncol. 2005 Nov;99(2):352-7. doi: 10.1016/j.ygyno.2005.06.005. Epub 2005 Aug 1. Gynecol Oncol. 2005. PMID: 16055176

7

Salvage cytoreductive surgery for recurrent endometrial cancer.

Bristow RE, Santillan A, Zahurak ML, Gardner GJ, Giuntoli RL 2nd, Armstrong DK. Bristow RE, et al. Gynecol Oncol. 2006 Oct;103(1):281-7. doi: 10.1016/j.ygyno.2006.03.011. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16631236

8

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis.

Bristow RE, Chi DS. Bristow RE, et al. Gynecol Oncol. 2006 Dec;103(3):1070-6. doi: 10.1016/j.ygyno.2006.06.025. Epub 2006 Jul 27. Gynecol Oncol. 2006. PMID: 16875720

9

Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.

Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Karam AK, et al. Among authors: bristow re. Gynecol Oncol. 2007 Feb;104(2):377-80. doi: 10.1016/j.ygyno.2006.08.037. Epub 2006 Oct 2. Gynecol Oncol. 2007. PMID: 17014899

10

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.

Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE. Santillan A, et al. Among authors: bristow re. Gynecol Oncol. 2007 Mar;104(3):686-90. doi: 10.1016/j.ygyno.2006.10.020. Epub 2006 Dec 1. Gynecol Oncol. 2007. PMID: 17141302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters